A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency
Status:
Active, not recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
Study AG348-C-003 is a multicenter study designed to evaluate the safety and efficacy of
different dose levels of AG-348 (mitapivat) in participants with PK deficiency.